IIM
BCAX

INTECH Investment Management’s Bicara Therapeutics BCAX Stock Holding History

INTECH Investment Management’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Buy
+8,767
New +$196K ﹤0.01% 1655
2026
Q1 		– Sell
-14,103
Closed -$237K – 2385
2025
Q4 		$237K Buy
14,103
+65
+0.5% +$1.11K ﹤0.01% 1880
2025
Q3 		$222K Sell
14,038
-13,635
-49% -$153K ﹤0.01% 2003
2025
Q2 		$257K Buy
27,673
+10,927
+65% +$130K ﹤0.01% 1963
2025
Q1 		$218K Buy
+16,746
New +$222K ﹤0.01% 2046

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

INTECH Investment Management's BCAX Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Bicara Therapeutics (BCAX) in Q2 2026: 8,767 shares worth $260K. The stake represents ﹤0.01% of the portfolio and ranks #1655 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in BCAX as recently as Q4 2025.

INTECH Investment Management first reported a position in BCAX in Q1 2025 and has held it in 5 quarters since. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • INTECH Investment Management held 8,767 shares of Bicara Therapeutics worth $260K as of Q2 2026.
  • Bicara Therapeutics was a new INTECH Investment Management position in Q2 2026.
  • Bicara Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1655 holding.
  • INTECH Investment Management first reported a position in Bicara Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.